Market cap
$227.949 M
$2.41 +4.78%
Close of 7 Aug 2026
Revenue
$72.8M
#2621 by revenue
Earnings
$35.3M
#1697 by earnings
Shares outstanding
94,553,191
Latest filing cover page
P/E ratio
6.4
Cap ÷ net income
Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap
All 160 →Where these numbers come from
Share counts and financials for Compugen are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.